- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07740213
Obstructive Sleep Apnea Among Patients Attending Sohag University Hospitals
July 30, 2026 updated by: Mohamed Kamal Abdelsattar Atta, Sohag University
Obstructive Sleep Apnea Among Patients Attending Sohag University Hospitals: Clinical Characteristics, Disease Severity and Comorbidities.
The goal of this observational study is to assess the clinical characteristics, severity and comorbidities of obstructive sleep apnea among patients attending Chest diseases and Tuberclosis department in Sohag University Hospitals
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sohag Governorate
-
Sohag, Sohag Governorate, Egypt, 82511
- Sohag University Hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients attending Sohag University Hospitals
Description
Inclusion Criteria:
- Age ≥18 years old.
- Patients with confirmed OSA diagnosis based on clinical and polysomnographic data.
Exclusion Criteria:
- Age < 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Detection of degree of severity of Obstructive Sleep Apnea
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
Clarifying different clinical characteristics of Obstructive Sleep Apnea
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
Detection of different comorbidities associated with Obstructive Sleep Apnea
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
July 27, 2026
First Submitted That Met QC Criteria
July 30, 2026
First Posted (Actual)
July 31, 2026
Study Record Updates
Last Update Posted (Actual)
July 31, 2026
Last Update Submitted That Met QC Criteria
July 30, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Obstructive Sleep Apnea
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.